Background illustration for clinical trials search

Paid Clinical Trials Chula Vista

Discover 1,279 paid clinical trials in Chula Vista, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder

for
Alcohol Use Disorder
Location: San Diego CA
Sponsor: VA Office of Research and Development

Sex: All

Age: 21 - 65

Code: NCT06399653

Recruiting

RCT of a Weighted Blanket to Reduce Pain in Veterans With Chronic Pain

for
Chronic Pain, Sleep Disturbance
Location: San Diego CA, San Francisco CA
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT05963607

Recruiting

A Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD

for
Post Traumatic Stress Disorder
Location: San Diego CA
Sponsor: United States Department of Defense

Sex: All

Age: 18+

Code: NCT06990191

Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: La Jolla CA, Los Alamitos CA, Beverly Hills CA,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase3, Recruiting

Pancreatic Cancer Early Detection Consortium

for
Pancreas Cancer, Pancreas Cyst,
Location: La Jolla CA, Newport Beach CA, Orange CA, Duarte CA,
Sponsor: Arbor Research Collaborative for Health

Sex: All

Age: 18 - 70+

Code: NCT04970056

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: La Jolla CA, Gilbert AZ, Oklahoma City OK, Houston TX,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT06241456

Phase1, Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for
Myelodysplastic Syndromes
Location: La Jolla CA, Duarte CA, Glendale CA, Henderson NV,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06499285

Phase3, Recruiting

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma,
Location: La Jolla CA, Los Angeles CA, Sacramento CA, Houston TX,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT04429542

Phase1, Recruiting

A Study of ICP-192 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors, Urothelial Carcinoma, Cholangiocarcinoma
Location: La Jolla CA, Tucson AZ, Aurora CO, Houston TX,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18+

Code: NCT04565275

Phase1, Phase2, Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Breast Cancer,
Location: San Diego CA, Duarte CA, Los Angeles CA, Seattle WA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06625775

Phase1, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: La Jolla CA, Pasadena CA, Phoenix AZ, Gilbert AZ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: La Jolla CA, Orange CA, Los Angeles CA, Phoenix AZ,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

for
Non-Small Cell Lung Cancer, NSCLC,
Location: San Diego CA, Los Angeles CA, San Francisco CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06917079

Phase1, Recruiting

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

for
HIV Infection, Tobacco-Related Carcinoma
Location: La Jolla CA, Seattle WA, Houston TX, St Louis MO,
Sponsor: AIDS Malignancy Consortium

Sex: All

Age: 45 - 70+

Code: NCT04949464

Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: San Diego CA, Irvine CA, Duarte CA, Gilbert AZ,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase1, Phase2, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: La Jolla CA, Santa Monica CA, San Francisco CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase1, Recruiting

TERPS Trial for de Novo Oligometastic Prostate Cancer

for
Prostate Cancer, Oligometastatic Disease
Location: La Jolla CA, Kansas City KS, Pittsburgh PA,
Sponsor: University of Maryland, Baltimore

Sex: Male

Age: 18+

Code: NCT05223803

Phase2, Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

for
Solid Tumors, Hematologic Malignancies
Location: La Jolla CA, Duarte CA, Houston TX, Omaha NE,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07195916

Phase1, Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

for
Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm,
Location: La Jolla CA, San Francisco CA, Salt Lake City UT,
Sponsor: AIDS Malignancy Consortium

Sex: All

Age: 18+

Code: NCT05663502

Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: La Jolla CA, Los Angeles CA, Scottsdale AZ,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase2, Phase3, Recruiting